114 related articles for article (PubMed ID: 17473221)
1. The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy.
Friedman DJ; Rennke HG; Csizmadia E; Enjyoji K; Robson SC
Diabetes; 2007 Sep; 56(9):2371-9. PubMed ID: 17473221
[TBL] [Abstract][Full Text] [Related]
2. Deletion of cd39/entpd1 results in hepatic insulin resistance.
Enjyoji K; Kotani K; Thukral C; Blumel B; Sun X; Wu Y; Imai M; Friedman D; Csizmadia E; Bleibel W; Kahn BB; Robson SC
Diabetes; 2008 Sep; 57(9):2311-20. PubMed ID: 18567823
[TBL] [Abstract][Full Text] [Related]
3. Functional ENTPD1 polymorphisms in African Americans with diabetes and end-stage renal disease.
Friedman DJ; Talbert ME; Bowden DW; Freedman BI; Mukanya Y; Enjyoji K; Robson SC
Diabetes; 2009 Apr; 58(4):999-1006. PubMed ID: 19095759
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy.
Nicholas SB; Aguiniga E; Ren Y; Kim J; Wong J; Govindarajan N; Noda M; Wang W; Kawano Y; Collins A; Hsueh WA
Kidney Int; 2005 Apr; 67(4):1297-307. PubMed ID: 15780082
[TBL] [Abstract][Full Text] [Related]
5. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
Masuda K; Tanabe K; Ujike H; Hinamoto N; Miyake H; Tanimura S; Sugiyama H; Sato Y; Maeshima Y; Wada J
PLoS One; 2018; 13(4):e0195779. PubMed ID: 29641565
[TBL] [Abstract][Full Text] [Related]
6. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.
Jackson SW; Hoshi T; Wu Y; Sun X; Enjyoji K; Cszimadia E; Sundberg C; Robson SC
Am J Pathol; 2007 Oct; 171(4):1395-404. PubMed ID: 17823293
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease.
Lassila M; Fukami K; Jandeleit-Dahm K; Semple T; Carmeliet P; Cooper ME; Kitching AR
Diabetologia; 2007 Jun; 50(6):1315-26. PubMed ID: 17415547
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5'-nucleotidase in pig endothelial cells.
De Giorgi M; Pelikant-Malecka I; Sielicka A; Slominska EM; Giovannoni R; Cinti A; Cerrito MG; Lavitrano M; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):313-8. PubMed ID: 24940685
[TBL] [Abstract][Full Text] [Related]
10. Novel Plasminogen Activator Inhibitor-1 Inhibitors Prevent Diabetic Kidney Injury in a Mouse Model.
Jeong BY; Uddin MJ; Park JH; Lee JH; Lee HB; Miyata T; Ha H
PLoS One; 2016; 11(6):e0157012. PubMed ID: 27258009
[TBL] [Abstract][Full Text] [Related]
11. NTPDase1 governs P2X7-dependent functions in murine macrophages.
Lévesque SA; Kukulski F; Enjyoji K; Robson SC; Sévigny J
Eur J Immunol; 2010 May; 40(5):1473-85. PubMed ID: 20201036
[TBL] [Abstract][Full Text] [Related]
12. Nucleoside triphosphate diphosphohydrolase-1 ectonucleotidase is required for normal vas deferens contraction and male fertility through maintaining P2X1 receptor function.
Kauffenstein G; Pelletier J; Lavoie EG; Kukulski F; Martín-Satué M; Dufresne SS; Frenette J; Ribas Fürstenau C; Sereda MJ; Toutain B; Henrion D; Sullivan R; Vial C; Sévigny J
J Biol Chem; 2014 Oct; 289(41):28629-39. PubMed ID: 25160621
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G
Kidney Int; 2014 Nov; 86(5):979-90. PubMed ID: 24827776
[TBL] [Abstract][Full Text] [Related]
14. NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney.
Zhu K; Kakehi T; Matsumoto M; Iwata K; Ibi M; Ohshima Y; Zhang J; Liu J; Wen X; Taye A; Fan C; Katsuyama M; Sharma K; Yabe-Nishimura C
Free Radic Biol Med; 2015 Jun; 83():21-30. PubMed ID: 25701431
[TBL] [Abstract][Full Text] [Related]
15. Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null mice.
Sun X; Han L; Seth P; Bian S; Li L; Csizmadia E; Junger WG; Schmelzle M; Usheva A; Tapper EB; Baffy G; Sukhatme VP; Wu Y; Robson SC
Hepatology; 2013 Jan; 57(1):205-16. PubMed ID: 22859060
[TBL] [Abstract][Full Text] [Related]
16. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.
Al-Douahji M; Brugarolas J; Brown PA; Stehman-Breen CO; Alpers CE; Shankland SJ
Kidney Int; 1999 Nov; 56(5):1691-9. PubMed ID: 10571777
[TBL] [Abstract][Full Text] [Related]
17. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
[TBL] [Abstract][Full Text] [Related]
18. Purinergic dysregulation in pulmonary hypertension.
Visovatti SH; Hyman MC; Goonewardena SN; Anyanwu AC; Kanthi Y; Robichaud P; Wang J; Petrovic-Djergovic D; Rattan R; Burant CF; Pinsky DJ
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H286-98. PubMed ID: 27208163
[TBL] [Abstract][Full Text] [Related]
19. The Role of Bone Marrow Cells in the Phenotypic Changes Associated with Diabetic Nephropathy.
Yang G; Cheng Q; Liu S; Zhao J
PLoS One; 2015; 10(9):e0137245. PubMed ID: 26340671
[TBL] [Abstract][Full Text] [Related]
20. Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors.
Schaefer U; Machida T; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2007 Sep; 322(3):1269-77. PubMed ID: 17565006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
